Showing results (211-220 of 464) with videos related to
Sort By:
Pageof 47
Pituitary|August 13, 2015
Extended transsphenoidal approach for pituitary adenomas invading the cavernous sinus using multiple complementary techniquesXinjie Bao, Kan Deng, Xiaohai Liu, et al.Surgical Neurology International|April 30, 2016
The role of surgery for treatment of low back pain: insights from the randomized controlled Spine Patient Outcomes Research TrialsPeter Abraham, Robert C Rennert, Joel R Martin, et al.Neurosurgery|June 22, 2017
Risk Factors for Readmission with Cerebrospinal Fluid Leakage Within 30 Days of Vestibular Schwannoma SurgeryAli A Alattar, Brian R Hirshman, Brandon A McCutcheon, et al.World Neurosurgery|May 4, 2019
Stereotactic Laser Ablation as Treatment of Brain Metastases Recurring after Stereotactic Radiosurgery: A Systematic Literature ReviewAli A Alattar, Jiri Bartek, Veronica L Chiang, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 5, 2017
The use of TMZ embedded hydrogels for the treatment of orthotopic human glioma xenograftsBandita Adhikari, Jie Li, Michael G Brandel, et al.Neurosurgical Focus|October 4, 2016
Safety of stereotactic laser ablations performed as treatment for glioblastomas in a conventional magnetic resonance imaging suiteRobert C Rennert, Kate T Carroll, Mir Amaan Ali, et al.Journal of Neuro-Oncology|September 1, 2019
Receipt of brachytherapy is an independent predictor of survival in glioblastoma in the Surveillance, Epidemiology, and End Results databaseJiri Bartek, Ali A Alattar, Sanjay Dhawan, et al.Progress in Neurological Surgery|July 11, 2018
Extracellular Vesicles as a Platform for Glioma Therapeutic DevelopmentDavid R Santiago-Dieppa, David D Gonda, Vincent J Cheung, et al.Emerging Infectious Diseases|May 1, 2009
Use of unstructured event-based reports for global infectious disease surveillanceMikaela Keller, Michael Blench, Herman Tolentino, et al.The Journal of Biological Chemistry|April 4, 2015
Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and InvasionAndrew S Gilder, Karra A Jones, Jingjing Hu, et al.Pageof 47